- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies | ||
| Mi | Recipharm and PLG to support pharma companies in expediting market approval | ||
| Mi | How to manage the complexities of synthetic API production in 30 steps | ||
| Mi | GSK to spend $2bn on Phase III liver disease drug acquisition | ||
| Mi | Stylus Medicine launches with $85m to advance in vivo gene editing | ||
| Mi | Eligo Bioscience secures grant to advance topical gene delivery platform | ||
| Mi | GSK and iTeos drop anti-TIGIT drug following trial failure | ||
| Mi | Japan's MHLW approves Sarepta's gene therapy for DMD | ||
| Di | Orphan drug market access in Europe: HTA challenges and the growing potential of RWE | ||
| Di | Reducing patient burden in rare disease trials: DCTs for increased patient centricity | ||
| Di | FDA clears Ensoma's application for rare genetic disorder treatment | ||
| Di | How to transform EHR data into useful clinical insights using AI | ||
| Di | Pharma faces 30-day deadline under Trump's pricing order | ||
| Di | EC grants orphan drug status to Biodexa's oral FAP treatment | ||
| Di | Republicans' proposed Medicaid cuts met with dismay | ||
| Di | Abeona secures cash runway with $155m priority review voucher sale | ||
| Di | GLP-1RAs show anti-cancer benefits beyond weight loss | ||
| Di | MHRA approves AstraZeneca's Trixeo Aerosphere inhaler for COPD | ||
| Mo | Roche plans $700m manufacturing plant in the US | ||
| Mo | Novo Nordisk's Sogroya matches Norditropin in children's growth disorders | ||
| Mo | Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China | ||
| Mo | The advantages of isolator lines for large-scale pharma manufacturing | ||
| Mo | Trump to sign order tying US drug prices to global rates | ||
| Mo | LENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatment | ||
| Mo | Valneva's chikungunya vaccine use halted in older adults amid safety concerns |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .